BIVI
BIOVIE INC.
NASDAQ · Healthcare · Biotechnology · US
$1.38
−5.48%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-214.9%
Return on equity
-154.9%
Return on assets
-214.8%
Return on invested capital
0.00x
Asset turnover
-$19.0M
Cash from operations
$1.03
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026